Please use this identifier to cite or link to this item:
doi:10.22028/D291-42221
Title: | Impact of four different extraction methods and three different reconstitution solvents on the untargeted metabolomics analysis of human and rat urine samples |
Author(s): | Hemmer, Selina Manier, Sascha K. Wagmann, Lea Meyer, Markus R. |
Language: | English |
Title: | Journal of chromatography. A |
Volume: | 1725 |
Publisher/Platform: | Elsevier |
Year of Publication: | 2024 |
Free key words: | Untargeted metabolomics Human urine Rat urine Extraction methods Reconstitution Sample preparation |
DDC notations: | 610 Medicine and health |
Publikation type: | Journal Article |
Abstract: | Unsuitable sample preparation may result in loss of important analytes and consequently affect the outcome of untargeted metabolomics. Due to species differences, different sample preparations may be required within the same biological matrix. The study aimed to compare the in-house sample preparation method for urine with methods from literature and to investigate the transferability of sample preparation from human urine to rat urine. A total of 12 different conditions for protein precipitation were tested, combining four different extraction solvents and three different reconstitution solvents using an untargeted liquid-chromatography high resolution mass spectrometry (LCHRMS) metabolomics analysis. Evaluation was done based on the impact on feature count, their detectability, as well as the reproducibility of selected compounds. Results showed that a combination of methanol as extraction and acetonitrile/water (75/25) as reconstitution solvent provided improved results at least regarding the total feature count. Additionally, it was found that a higher amount of methanol was most suitable for extraction of rat urine among the tested conditions. In comparison, human urine requires significantly less volume of extraction solvent. Overall, it is recommended to systematically optimize both, the extraction method, and the reconstitution solvent for the used biofluid and the individual analytical settings. |
DOI of the first publication: | 10.1016/j.chroma.2024.464930 |
URL of the first publication: | https://doi.org/10.1016/j.chroma.2024.464930 |
Link to this record: | urn:nbn:de:bsz:291--ds-422216 hdl:20.500.11880/37900 http://dx.doi.org/10.22028/D291-42221 |
ISSN: | 0021-9673 |
Date of registration: | 20-Jun-2024 |
Description of the related object: | Supplementary materials |
Related object: | https://ars.els-cdn.com/content/image/1-s2.0-S0021967324003042-mmc1.pdf |
Faculty: | M - Medizinische Fakultät |
Department: | M - Experimentelle und Klinische Pharmakologie und Toxikologie |
Professorship: | M - Prof. Dr. Markus Meyer |
Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0021967324003042-main.pdf | 1,23 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License